Skip to main content
SpringerLink
Log in

Omalizumab

Recurrent upper respiratory tract infection: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Hauswald B, et al. Safe and effective hyposensitization in bakers suffering from year-round allergic rhinoconjunctivitis and allergic bronchial asthma caused by flour dust allergy. Allergo Journal International 27: 43-48, No. 2, Mar 2018. Available from: URL: http://doi.org/10.1007/s40629-018-0052-4 -Germany

    Article  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Omalizumab. Reactions Weekly 1696, 290 (2018). https://doi.org/10.1007/s40278-018-44478-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-018-44478-2

Search

Navigation